Bank of America’s Argos Therapeutics, Inc. ARGS Stock Holding History
Bought
Maintained
Sold
Other funds holding ARGS
Bank of America's ARGS Position: Q2 2018 in Review
Bank of America sold out of Argos Therapeutics, Inc. (ARGS) in Q2 2018, closing a stake of 293 shares.
Bank of America first reported a position in ARGS in Q2 2014 and held it in 11 quarters. The position peaked at $134K in Q2 2014. 4 funds tracked by Wall St. Rank hold ARGS as of Q2 2018.
- Bank of America reported no remaining Argos Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
- Bank of America sold 293 Argos Therapeutics, Inc. shares in Q2 2018.
- Bank of America first reported a position in Argos Therapeutics, Inc. in Q2 2014 and held it in 11 quarters.
- Bank of America's Argos Therapeutics, Inc. position peaked at $134K in Q2 2014.
- 4 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q2 2018.
Based on Bank of America's 13F filing for Q2 2018, filed 14 Aug 2018.